Clinical Research Directory
Browse clinical research sites, groups, and studies.
Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer Survivors
Sponsor: University Hospital Schleswig-Holstein
Summary
The main goal of this trial is to identify the optimal cut-off score of a Scoring System to discriminate between mild chemotherapy-induced peripheral neuropathy (CIPN) and no CIPN in breast cancer survivors previously treated with taxane-based chemotherapy and adjuvant radiotherapy.
Official title: Chemotherapy-induced Peripheral Neuropathy - Additional Evaluation of a Self-administered Scoring System for Breast Cancer Survivors
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2026-06-01
Completion Date
2026-08-31
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Interventions
Symptom-based scoring system
The patients will be asked to complete the self-evaluation of symptoms and signs of neuropathy using a Neuropathy Tracker that questions symptoms quality, severity and distribution and guide the user through a systematic evaluation of pin-prick from a needle and vibration from the mobile on successive levels from the toes to the knee on both legs. Finally, the extension force or both great toes will be self-assessed by the participant. The self-examination is based on the structure of the Utah Early Neuropathy Score.
Locations (1)
Department of Radiation Oncology, University of Luebeck
Lübeck, Schleswig-Holstein, Germany